Department of Radiology, Zhujiang Hospital, Southern Medical University, Haizhu District, 253 Gongye Middle Avenue, Guangzhou, Guangdong, 510282, China.
BMC Med Imaging. 2024 Apr 10;24(1):85. doi: 10.1186/s12880-024-01262-z.
1p/19q co-deletion in low-grade gliomas (LGG, World Health Organization grade II and III) is of great significance in clinical decision making. We aim to use radiomics analysis to predict 1p/19q co-deletion in LGG based on amide proton transfer weighted (APTw), diffusion weighted imaging (DWI), and conventional MRI.
This retrospective study included 90 patients histopathologically diagnosed with LGG. We performed a radiomics analysis by extracting 8454 MRI-based features form APTw, DWI and conventional MR images and applied a least absolute shrinkage and selection operator (LASSO) algorithm to select radiomics signature. A radiomics score (Rad-score) was generated using a linear combination of the values of the selected features weighted for each of the patients. Three neuroradiologists, including one experienced neuroradiologist and two resident physicians, independently evaluated the MR features of LGG and provided predictions on whether the tumor had 1p/19q co-deletion or 1p/19q intact status. A clinical model was then constructed based on the significant variables identified in this analysis. A combined model incorporating both the Rad-score and clinical factors was also constructed. The predictive performance was validated by receiver operating characteristic curve analysis, DeLong analysis and decision curve analysis. P < 0.05 was statistically significant.
The radiomics model and the combined model both exhibited excellent performance on both the training and test sets, achieving areas under the curve (AUCs) of 0.948 and 0.966, as well as 0.909 and 0.896, respectively. These results surpassed the performance of the clinical model, which achieved AUCs of 0.760 and 0.766 on the training and test sets, respectively. After performing Delong analysis, the clinical model did not significantly differ in predictive performance from three neuroradiologists. In the training set, both the radiomic and combined models performed better than all neuroradiologists. In the test set, the models exhibited higher AUCs than the neuroradiologists, with the radiomics model significantly outperforming resident physicians B and C, but not differing significantly from experienced neuroradiologist.
Our results suggest that our algorithm can noninvasively predict the 1p/19q co-deletion status of LGG. The predictive performance of radiomics model was comparable to that of experienced neuroradiologist, significantly outperforming the diagnostic accuracy of resident physicians, thereby offering the potential to facilitate non-invasive 1p/19q co-deletion prediction of LGG.
1p/19q 共缺失在低级别胶质瘤(LGG,世界卫生组织分级 II 和 III)的临床决策中具有重要意义。我们旨在使用放射组学分析基于酰胺质子转移加权(APTw)、弥散加权成像(DWI)和常规 MRI 来预测 LGG 中的 1p/19q 共缺失。
本回顾性研究纳入了 90 例经组织病理学诊断为 LGG 的患者。我们通过提取 APTw、DWI 和常规 MRI 图像中的 8454 个基于 MRI 的特征进行放射组学分析,并应用最小绝对收缩和选择算子(LASSO)算法选择放射组学特征。使用线性组合为每个患者的选定特征赋值生成放射组学评分(Rad-score)。三位神经放射科医生(包括一位经验丰富的神经放射科医生和两位住院医师)独立评估 LGG 的 MRI 特征,并对肿瘤是否存在 1p/19q 共缺失或 1p/19q 完整状态进行预测。然后基于该分析中确定的显著变量构建临床模型。还构建了一种结合 Rad-score 和临床因素的综合模型。通过接受者操作特征曲线分析、DeLong 分析和决策曲线分析验证预测性能。P<0.05 为统计学显著。
放射组学模型和综合模型在训练集和测试集上均表现出优异的性能,曲线下面积(AUC)分别为 0.948 和 0.966,以及 0.909 和 0.896。这些结果优于临床模型的性能,后者在训练集和测试集上的 AUC 分别为 0.760 和 0.766。进行 DeLong 分析后,临床模型在预测性能方面与三位神经放射科医生没有显著差异。在训练集中,放射组学模型和综合模型的表现均优于所有神经放射科医生。在测试集中,模型的 AUC 高于神经放射科医生,放射组学模型显著优于住院医师 B 和 C,但与经验丰富的神经放射科医生没有显著差异。
我们的结果表明,我们的算法可以无创预测 LGG 的 1p/19q 共缺失状态。放射组学模型的预测性能与经验丰富的神经放射科医生相当,显著优于住院医师的诊断准确性,从而有可能促进 LGG 中 1p/19q 共缺失的无创预测。